ORS 743A.114: Perimenopause, menopause and postmenopause.

(1) All health benefit plans, as defined in ORS 743B.005, shall include coverage of the treatment of perimenopause, menopause and postmenopause, including but not limited to the following:

      (a) Hormone therapy including combination estrogen and hormone medicines, combination estrogen and progesterone medicines and estrogen-only medicines;

      (b) SSRIs and SNRIs;

      (c) Vaginal estrogen;

      (d) Medications to prevent or treat osteoporosis;

      (e) Neurokinin B antagonists;

      (f) Topical hormone therapy; and

      (g) Bioidentical hormones.

      (2) The coverage required in this section is limited to drugs that have been approved by the United States Food and Drug Administration.

      (3) This section is exempt from ORS 743A.001.